Primary Prophylaxis for Spontaneous Bacterial Peritonitis

NCT04775329 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment and study closure

Conditions

Decompensated Cirrhosis
Small Bowel Bacterial Overgrowth Syndrome

Interventions

DRUG: Rifaximin

Sponsor

Changi General Hospital